4 recruiting, 2 not yet recruiting. 3 Phase 2, 2 Not applicable, 1 Phase 1.
By phase and status
Follow Liu Huang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer
Fruquintinib+Irinotecan Liposome+Capecitabine, Bevacizumab+Irinotecan Liposome+Capecitabine - Colorectal Cancer (CRC) | Phase 2 | Not yet recruiting | Liu Huang | 68 | 2025-07-07 | 2025-07-04 |
An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations.
Tunlametinib combined with Fruquintinib - CRC, Colorectal Cancer | Not applicable | Not yet recruiting | Liu Huang | 34 | 2025-05-19 | 2025-05-22 |
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Glumetinib Combined with Fruquintinib - Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Liu Huang | 42 | 2025-04-25 | 2025-05-20 |
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Fruquintinib, Cadonilimab, SBRT - Metastatic Colorectal Cancer | Not applicable | Recruiting | Liu Huang | 80 | 2024-08-20 | 2024-08-13 |
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Paclitaxel Polymeric Micelles for Injection - Pancreatic Adenocarcinoma, Cholangiocarcinoma | Phase 2 | Recruiting | Liu Huang | 25 | 2023-11-28 | 2025-06-03 |
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing. - Lung Cancer, Breast Cancer | | Recruiting | Liu Huang | 55 | 2023-08-04 | 2025-06-04 |
Conditions studied
Colorectal Neoplasms (5) · Breast Neoplasms (2) · Lung Neoplasms (2) · Stomach Neoplasms (2) · Cholangiocarcinoma (1) · Esophageal Neoplasms (1)
Interventions
HMPL-013 (3) · Injections (1)
Countries
China (4)
Top investigators
Xianglin Yuan (1)